Sponsor Dossier
Aspen Pharmacare
Sponsor Dossier for Aspen Pharmacare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALDOMET
- Brand: ALENAMI
- Brand: ALKERAN
- Brand: ALPRAX
- Brand: AMOXIL
- Brand: AMYTAL
- Brand: ANAGRAINE
- Brand: APO-TEMAZEPAM
- Device (sponsor): Medicine administration kit atomizer
- Device (sponsor): Gastro-oesophageal antireflux barrier
- Device (sponsor): Dropper, <specify>
- Device (sponsor): Medication spray nozzle
- Device (sponsor): Medication spray nozzle
- Device (sponsor): Vaginal applicator/medicine kit
- Device (sponsor): Dropper, <specify>
About
Aspen Pharmacare is an Australian Private Company with ABN 51 096 236 985, registered in New South Wales. The company is active and has been registered for goods and services tax purposes since 2001.
Portfolio
Aspen Pharmacare has 171 brands on the ARTG, of which 126 are indexable and 119 carry a Product Information document. 93 brands are PBS-listed, 9 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include ALDOMET, ALENAMI, ALKERAN, ALPRAX, AMOXIL, AMYTAL, ANAGRAINE, APO-TEMAZEPAM, ARISTOCORT, ARIXTRA, AROPAX, ASPEN.
Therapeutic focus
— Infectious Disease: 30 brands — Pain Management: 23 brands — Cardiology: 13 brands — Psychiatry: 12 brands — Neurology: 12 brands — Endocrinology: 11 brands — Dermatology: 11 brands — Oncology: 9 brands — Immunology: 8 brands — Gastroenterology: 7 brands — Ophthalmology: 7 brands — Haematology: 6 brands — Other: 6 brands — Musculoskeletal: 4 brands — Complementary Medicine: 4 brands — Reproductive Health: 3 brands — Respiratory: 3 brands — Renal: 2 brands
PBS footprint
93 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2023-12-01, across 9 brands with a PBAC outcome on record. The latest AusPAR is 2025-07-29, across 2 brands with an AusPAR on record.